Lack of Differences in the Pharmacokinetics of Therapeutic Monoclonal Antibodies Between Japanese and Non‐Japanese Individuals

Journal of Clinical Pharmacology · Published 2026-07-30 · DOI 10.1002/jcph.70245

Free full text

Authors (3)

Paridhi Gupta, Ashish Sharma, Bernd Meibohm

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gupta, P., Sharma, A., Meibohm, B. (2026). Lack of Differences in the Pharmacokinetics of Therapeutic Monoclonal Antibodies Between Japanese and Non‐Japanese Individuals. Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70245

Related articles

• Comment on “Understanding Atomoxetine Exposure Variability in Children and Adolescents with ADHD through Population Pharmacokinetics” · Journal of Clinical Pharmacology · 2026 · Same journal
• A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants with End‐Stage Kidney Disease on Hemodialysis · Journal of Clinical Pharmacology · 2026 · Same journal
• A Phase 1 Oral Mass Balance and Combined Intravenous [ 14 C] Microtracer Study to Characterize the Absorption, Metabolism, Excretion, and Pharmacokinetics of Antitumor Drug E7386 in Humans · Journal of Clinical Pharmacology · 2026 · Same journal
• Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine · Journal of Clinical Pharmacology · 2026 · Same journal
• Volumetric Absorptive Microsampling During Spaceflight for Analysis of Acetaminophen Pharmacokinetics in Whole Blood · Journal of Clinical Pharmacology · 2026 · Same journal
• Decoupling CAR‐T Expansion, Conversion, and Decay Timing: Physiologically Aligned Semi‐Mechanistic Modeling With Smooth Gating and a Cauchy Likelihood Residual Model · Journal of Clinical Pharmacology · 2026 · Same journal
• Hepatic CYP1A2 Activity in Adolescents with and without Obesity Assessed by the Urinary Paraxanthine‐to‐Caffeine Metabolic Ratio: A Pharmacokinetic Study · Journal of Clinical Pharmacology · 2026 · Same journal
• Pharmacokinetics, Safety, and Tolerability of Anti‐miR‐17 Oligonucleotide RGLS4326 in Healthy Adult Subjects · Journal of Clinical Pharmacology · 2026 · Same journal
• Population Pharmacokinetics and Exposure‐Safety Analysis of Furosemide in Preterm Infants · Journal of Clinical Pharmacology · 2026 · Same journal
• Population Pharmacokinetics of Oral Gecacitinib in Healthy Subjects and Patients with Autoimmune and Inflammatory Diseases · Journal of Clinical Pharmacology · 2026 · Same journal